ARGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the data provided, Argenx SE (ARGX) does not present a strong buy opportunity for a beginner investor with a long-term strategy at this time. While the company's long-term growth potential is promising, the recent financial performance, lack of significant trading signals, and neutral sentiment from hedge funds and insiders suggest that it is better to hold off on investing for now.
The technical indicators are mixed. The MACD is positive and expanding, suggesting bullish momentum, but the RSI is neutral at 46.079, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 689.107, with resistance at 709.888 and support at 668.326.
The company has strong Vyvgart commercial momentum and is consistently profitable. Additionally, the company has 20 Phase II/III trials ongoing, which indicates a robust pipeline.
The recent financial performance shows a decline in net income (-31.16% YoY) and EPS (-30.98% YoY), despite revenue growth. Gross margin also dropped by 2%. There is no recent news or significant insider/hedge fund activity to suggest a strong near-term catalyst.
In 2025/Q4, revenue increased by 74.12% YoY to $1.285 billion, but net income dropped by 31.16% YoY to $532.95 million. EPS also declined by 30.98% YoY to $8.02, and gross margin decreased slightly to 88.36%.
Analysts are generally positive on the stock, with multiple firms maintaining Buy or Outperform ratings and raising price targets. Price targets range from $725 to $1,247, reflecting confidence in the company's long-term growth potential despite short-term challenges.
